NCT07288034 2026-04-15Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatment in Stage IIIB-IV Non-small Cell Lung Cancer, IMMUNO-BIOMAP TrialCity of Hope Medical CenterPhase 2 Recruiting535 enrolled
NCT02888743 2026-04-13Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung CancerNational Cancer Institute (NCI)Phase 2 Active not recruiting110 enrolled 21 charts